Lambert, Samuel A. http://orcid.org/0000-0001-8222-008X
Wingfield, Benjamin http://orcid.org/0000-0002-2913-0779
Gibson, Joel T. http://orcid.org/0000-0002-8967-4188
Gil, Laurent http://orcid.org/0000-0002-9475-4502
Ramachandran, Santhi
Yvon, Florent
Saverimuttu, Shirin
Tinsley, Emily
Lewis, Elizabeth
Ritchie, Scott C. http://orcid.org/0000-0002-8454-9548
Wu, Jingqin http://orcid.org/0000-0002-2052-3875
Cánovas, Rodrigo
McMahon, Aoife http://orcid.org/0000-0003-0978-0309
Harris, Laura W.
Parkinson, Helen
Inouye, Michael http://orcid.org/0000-0001-9413-6520
Funding for this research was provided by:
RCUK | Engineering and Physical Sciences Research Council (EP/T022159/1)
EC | Horizon 2020 Framework Programme (101016775 INTERVENE, 101016775 INTERVENE, 101016775 INTERVENE)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (1U24HG012542-01, 1U24HG012542-01)
European Bioinformatics Institute (Core Funds)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute
RCUK | Economic and Social Research Council (ES/T013192/1)
British Heart Foundation (RG/18/13/33946, RG/F/23/110103, RE/18/1/34212, RE/18/1/34212, CH/12/2/29428)
DH | National Institute for Health Research (BRC-1215–20014, NIHR203312)
Article History
First Online: 26 September 2024
Competing interests
: M.I. is a trustee of the Public Health Genomics Foundation; is a member of the Scientific Advisory Board of Open Targets; and has research collaborations with AstraZeneca, Nightingale Health and Pfizer that are unrelated to this study. All other authors declare no competing interests.